Mahzad Akbarpour to Antibodies, Monoclonal
This is a "connection" page, showing publications Mahzad Akbarpour has written about Antibodies, Monoclonal.
Connection Strength
0.096
-
Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy. Front Immunol. 2023; 14:1155778.
Score: 0.049
-
Advances in therapeutic targeting of immune checkpoints receptors within the CD96-TIGIT axis: clinical implications and future perspectives. Expert Rev Clin Immunol. 2022 Dec; 18(12):1217-1237.
Score: 0.047